Advanced search
1 file | 295.36 KB Add to list

Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance

Author
Organization
Abstract
Objective To reduce the inappropriate use of broad-spectrum antibiotics in a 1000+ bed acute tertiary care hospital by the introduction of cascade antimicrobial susceptibility reporting for Enterobacterales. Methods Over a 1-year period, we selectively suppressed reporting of susceptibility to the broad-spectrum antibiotics piperacillin-tazobactam (TZP) and meropenem (MEM) for Enterobacterales strains susceptible to amoxicillin-clavulanic acid (AMC) and negative for extended-spectrum beta-lactamase (ESBL). We measured the effects on hospital-wide antibiotic consumption (defined daily doses/1000 admissions) and resistance of Escherichia coli and Klebsiella pneumoniae on two levels. First, we compared resistance and antibiotic use for the antibiotics impacted by the intervention (AMC, TZP and MEM) with control antibiotics that were consistently reported (fluoroquinolones, trimethoprim-sulfamethoxazole and third-generation cephalosporins). Second, we compared the resistance for TZP and MEM with a control pathogen (Pseudomonas aeruginosa) and studied the impact on rate of Clostridioides difficile-associated diarrhoea in our hospital. Results We observed an overall increased use of AMC relative to overall antibiotic consumption (20.0%, p<0.0001) together with a decreased use of TZP (-11.9%, p=0.049) and unchanged use of MEM (p=0.68) relative to overall antibiotic consumption. As for resistance, the number of ESBL-positive K. pneumoniae strains diminished by 5.9% (p<0.0001). When focusing on intensive care units, the carbapenemase-producing Enterobacterales (CPE) rate also decreased by 4.5% (p=0.0091). For E. coli, no significant difference in ESBL (p=0.33) and CPE (p=0.48) rates were observed. No significant difference in the rate of C. difficile infections was observed (p=0.40). Conclusions Restricted susceptibility reporting of TZP and MEM was associated with a significant increased use of AMC and decreased use of TZP relative to overall antibiotic consumption and significant reduction in ESBL- and CPE-positive K. pneumoniae strains.
Keywords
microbiology, laboratories, hospital, microbiological techniques, clinical medicine, clinical laboratory techniques, INFECTIOUS-DISEASES SOCIETY, URINARY-TRACT-INFECTIONS, HEALTH-CARE EPIDEMIOLOGY, IMPACT, APPROPRIATENESS, STEWARDSHIP, GUIDELINES, AMERICA, PROGRAM

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 295.36 KB

Citation

Please use this url to cite or link to this publication:

MLA
Heireman, Laura, et al. “Effects of Cascade Reporting of Susceptibility Profiles for Enterobacterales on Broad-Spectrum Antibiotics Use and Resistance.” EUROPEAN JOURNAL OF HOSPITAL PHARMACY, vol. 29, no. 2, 2022, pp. 79–83, doi:10.1136/ejhpharm-2021-002951.
APA
Heireman, L., Vandendriessche, S., Coorevits, L., Buyle, F., De Waele, J., Vogelaers, D., … Boelens, J. (2022). Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance. EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 29(2), 79–83. https://doi.org/10.1136/ejhpharm-2021-002951
Chicago author-date
Heireman, Laura, Stien Vandendriessche, Liselotte Coorevits, Franky Buyle, Jan De Waele, Dirk Vogelaers, Bruno Verhasselt, and Jerina Boelens. 2022. “Effects of Cascade Reporting of Susceptibility Profiles for Enterobacterales on Broad-Spectrum Antibiotics Use and Resistance.” EUROPEAN JOURNAL OF HOSPITAL PHARMACY 29 (2): 79–83. https://doi.org/10.1136/ejhpharm-2021-002951.
Chicago author-date (all authors)
Heireman, Laura, Stien Vandendriessche, Liselotte Coorevits, Franky Buyle, Jan De Waele, Dirk Vogelaers, Bruno Verhasselt, and Jerina Boelens. 2022. “Effects of Cascade Reporting of Susceptibility Profiles for Enterobacterales on Broad-Spectrum Antibiotics Use and Resistance.” EUROPEAN JOURNAL OF HOSPITAL PHARMACY 29 (2): 79–83. doi:10.1136/ejhpharm-2021-002951.
Vancouver
1.
Heireman L, Vandendriessche S, Coorevits L, Buyle F, De Waele J, Vogelaers D, et al. Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2022;29(2):79–83.
IEEE
[1]
L. Heireman et al., “Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance,” EUROPEAN JOURNAL OF HOSPITAL PHARMACY, vol. 29, no. 2, pp. 79–83, 2022.
@article{8747165,
  abstract     = {{Objective To reduce the inappropriate use of broad-spectrum antibiotics in a 1000+ bed acute tertiary care hospital by the introduction of cascade antimicrobial susceptibility reporting for Enterobacterales. Methods Over a 1-year period, we selectively suppressed reporting of susceptibility to the broad-spectrum antibiotics piperacillin-tazobactam (TZP) and meropenem (MEM) for Enterobacterales strains susceptible to amoxicillin-clavulanic acid (AMC) and negative for extended-spectrum beta-lactamase (ESBL). We measured the effects on hospital-wide antibiotic consumption (defined daily doses/1000 admissions) and resistance of Escherichia coli and Klebsiella pneumoniae on two levels. First, we compared resistance and antibiotic use for the antibiotics impacted by the intervention (AMC, TZP and MEM) with control antibiotics that were consistently reported (fluoroquinolones, trimethoprim-sulfamethoxazole and third-generation cephalosporins). Second, we compared the resistance for TZP and MEM with a control pathogen (Pseudomonas aeruginosa) and studied the impact on rate of Clostridioides difficile-associated diarrhoea in our hospital. Results We observed an overall increased use of AMC relative to overall antibiotic consumption (20.0%, p<0.0001) together with a decreased use of TZP (-11.9%, p=0.049) and unchanged use of MEM (p=0.68) relative to overall antibiotic consumption. As for resistance, the number of ESBL-positive K. pneumoniae strains diminished by 5.9% (p<0.0001). When focusing on intensive care units, the carbapenemase-producing Enterobacterales (CPE) rate also decreased by 4.5% (p=0.0091). For E. coli, no significant difference in ESBL (p=0.33) and CPE (p=0.48) rates were observed. No significant difference in the rate of C. difficile infections was observed (p=0.40). Conclusions Restricted susceptibility reporting of TZP and MEM was associated with a significant increased use of AMC and decreased use of TZP relative to overall antibiotic consumption and significant reduction in ESBL- and CPE-positive K. pneumoniae strains.}},
  author       = {{Heireman, Laura and Vandendriessche, Stien and Coorevits, Liselotte and Buyle, Franky and De Waele, Jan and Vogelaers, Dirk and Verhasselt, Bruno and Boelens, Jerina}},
  issn         = {{2047-9956}},
  journal      = {{EUROPEAN JOURNAL OF HOSPITAL PHARMACY}},
  keywords     = {{microbiology,laboratories,hospital,microbiological techniques,clinical medicine,clinical laboratory techniques,INFECTIOUS-DISEASES SOCIETY,URINARY-TRACT-INFECTIONS,HEALTH-CARE EPIDEMIOLOGY,IMPACT,APPROPRIATENESS,STEWARDSHIP,GUIDELINES,AMERICA,PROGRAM}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{79--83}},
  title        = {{Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance}},
  url          = {{http://doi.org/10.1136/ejhpharm-2021-002951}},
  volume       = {{29}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: